2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

A Fanouriakis, M Kostopoulou, A Alunno… - Annals of the …, 2019 - ard.bmj.com
Our objective was to update the EULAR recommendations for the management of systemic
lupus erythematosus (SLE), based on emerging new evidence. We performed a systematic …

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

A Fanouriakis, M Kostopoulou, J Andersen… - Annals of the …, 2024 - ard.bmj.com
Objectives To update the EULAR recommendations for the management of systemic lupus
erythematosus (SLE) based on emerging new evidence. Methods An international Task …

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical …

GK Bertsias, JPA Ioannidis, J Boletis… - Annals of the …, 2008 - ard.bmj.com
Objective: Systemic lupus erythematosus (SLE) is a complex disease with variable
presentations, course and prognosis. We sought to develop evidence-based …

Systemic lupus erythematosus: state of the art on clinical practice guidelines

F Tamirou, L Arnaud, R Talarico, CA Scirè… - RMD open, 2019 - rmdopen.bmj.com
Systemic lupus erythematosus (SLE) is the paradigm of systemic autoimmune diseases
characterised by a wide spectrum of clinical manifestations with an unpredictable relapsing …

Lupus erythematosus 2020

J Narvaez - Medicina Clínica (English Edition), 2020 - Elsevier
Systemic lupus erythematosus (SLE) is a complex autoimmune multisystemic disease of
great clinical heterogeneity and significant potential morbidity and mortality. Although the …

European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies

M Mosca, C Tani, M Aringer, S Bombardieri… - Annals of the …, 2010 - ard.bmj.com
Objectives To develop recommendations for monitoring patients with systemic lupus
erythematosus (SLE) in clinical practice and observational studies and to develop a …

Current state of evidence on 'off-label'therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and …

M Aringer, H Burkhardt, GR Burmester… - Lupus, 2012 - journals.sagepub.com
Systemic lupus erythematosus (SLE) can be a severe and potentially life-threatening
disease that often represents a therapeutic challenge because of its heterogeneous organ …

EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis

I Parodis, C Girard-Guyonvarc'h, L Arnaud… - Annals of the …, 2024 - ard.bmj.com
Objective To develop evidence-based recommendations for the non-pharmacological
management of systemic lupus erythematosus (SLE) and systemic sclerosis (SSc). Methods …

Diagnosis, monitoring, and treatment of systemic lupus erythematosus: a systematic review of clinical practice guidelines

DJ Tunnicliffe, D Singh‐Grewal, S Kim… - Arthritis care & …, 2015 - Wiley Online Library
Objective Management of systemic lupus erythematosus (SLE) is complex and variability in
practices exists. Guidelines have been developed to help improve the management of SLE …

[HTML][HTML] Systemic lupus erythematosus (SLE) therapy: the old and the new

F Basta, F Fasola, K Triantafyllias… - Rheumatology and …, 2020 - Springer
Despite recent improvements in the treatment of systemic lupus erythematosus (SLE),
disease activity, comorbidities and drug toxicity significantly contribute to the risk of …